Diagnos Laboratorium Utama PT Tbk (JK:DGNS) — Stock Price

Rp232.00 IDR
▼ -1.69% today

Diagnos Laboratorium Utama PT Tbk (JK:DGNS) is currently trading at Rp232.00 IDR, down 1.69% today. Over the past 52 weeks, shares have ranged between Rp140.00 and Rp328.00. This page tracks Diagnos Laboratorium Utama PT Tbk's live share price on the JK exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Diagnos Laboratorium Utama PT Tbk.

Diagnos Laboratorium Utama PT Tbk (DGNS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Diagnos Laboratorium Utama PT Tbk's daily closing share price and trading volume on the JK exchange over the past year, giving a clear view of recent price momentum and liquidity.

Diagnos Laboratorium Utama PT Tbk Income Statement — Revenue, Profit & Earnings by Year

Diagnos Laboratorium Utama PT Tbk's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Rp163.07 Billion Rp145.70 Billion Rp192.89 Billion Rp302.18 Billion Rp183.17 Billion
Cost of Revenue Rp98.59 Billion Rp86.38 Billion Rp104.49 Billion Rp154.54 Billion Rp97.27 Billion
Gross Profit Rp64.49 Billion Rp59.31 Billion Rp88.40 Billion Rp147.64 Billion Rp85.90 Billion
Research & Development Rp759.20 Million Rp249.04 Million Rp586.17 Million Rp273.57 Million Rp593.36 Million
SG&A Rp61.51 Billion Rp63.68 Billion Rp65.33 Billion Rp52.15 Billion Rp16.26 Billion
Total Operating Expenses Rp62.27 Billion Rp73.67 Billion Rp70.74 Billion Rp66.37 Billion Rp18.87 Billion
Operating Income Rp2.22 Billion Rp-14.03 Billion Rp17.66 Billion Rp81.28 Billion Rp67.03 Billion
EBITDA Rp16.63 Billion Rp1.53 Billion Rp31.39 Billion Rp90.84 Billion Rp70.82 Billion
EBIT Rp1.75 Billion Rp-13.10 Billion Rp18.15 Billion Rp83.28 Billion Rp66.98 Billion
Interest Expense Rp881.83 Million Rp475.24 Million Rp817.98 Million Rp0.00 Rp0.00
Income Before Tax Rp863.76 Million Rp-13.57 Billion Rp17.33 Billion Rp83.28 Billion Rp66.98 Billion
Income Tax Expense Rp116.32 Million Rp83.00 Million Rp4.67 Billion Rp18.98 Billion Rp14.29 Billion
Net Income Rp747.44 Million Rp-13.66 Billion Rp12.66 Billion Rp64.30 Billion Rp52.69 Billion

Diagnos Laboratorium Utama PT Tbk Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Diagnos Laboratorium Utama PT Tbk's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Rp300.02 Billion Rp271.48 Billion Rp239.94 Billion Rp241.98 Billion Rp132.57 Billion
Total Current Assets Rp78.61 Billion Rp87.81 Billion Rp118.37 Billion Rp153.86 Billion Rp105.15 Billion
Cash & Equivalents — — — — —
Short-term Investments Rp959.59 Million Rp1.70 Billion Rp2.54 Billion Rp6.51 Billion —
Net Receivables Rp48.89 Billion Rp45.25 Billion Rp49.45 Billion Rp73.94 Billion Rp81.27 Billion
Inventory Rp5.04 Billion Rp5.14 Billion Rp6.57 Billion Rp7.76 Billion Rp5.81 Billion
Property, Plant & Equipment Rp202.43 Billion Rp164.25 Billion Rp109.22 Billion Rp87.11 Billion Rp20.11 Billion
Goodwill — — — — —
Total Liabilities Rp103.89 Billion Rp75.88 Billion Rp29.51 Billion Rp40.18 Billion Rp33.51 Billion
Total Current Liabilities Rp21.61 Billion Rp14.44 Billion Rp10.49 Billion Rp26.63 Billion Rp30.61 Billion
Long-term Debt Rp52.77 Billion Rp38.28 Billion Rp16.92 Billion Rp7.56 Billion Rp914.85 Million
Net Debt Rp67.88 Billion Rp40.76 Billion Rp-13.32 Billion Rp-38.28 Billion Rp-14.26 Billion
Total Stockholder Equity Rp196.13 Billion Rp195.59 Billion Rp210.43 Billion Rp201.80 Billion Rp99.07 Billion
Retained Earnings Rp132.27 Billion Rp131.52 Billion Rp145.17 Billion Rp132.51 Billion Rp74.21 Billion

Diagnos Laboratorium Utama PT Tbk Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Diagnos Laboratorium Utama PT Tbk generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Rp27.30 Billion Rp13.18 Billion Rp-6.02 Billion Rp58.87 Billion Rp26.23 Billion
Capital Expenditures Rp43.39 Billion Rp38.32 Billion Rp34.85 Billion Rp67.84 Billion Rp5.86 Billion
Free Cash Flow Rp-16.10 Billion Rp-25.14 Billion Rp-40.87 Billion Rp-8.97 Billion Rp20.36 Billion
Investing Cash Flow Rp-44.18 Billion Rp-42.39 Billion Rp-17.55 Billion Rp-75.57 Billion Rp-8.15 Billion
Financing Cash Flow Rp10.85 Billion Rp11.44 Billion Rp6.86 Billion Rp44.87 Billion Rp-2.93 Billion
Dividends Paid — — Rp0.00 Rp6.00 Billion Rp6.00 Billion
Stock-Based Compensation — — — — —
Depreciation Rp14.88 Billion Rp14.63 Billion Rp13.23 Billion Rp7.56 Billion Rp3.84 Billion
Change in Cash Rp-6.04 Billion Rp-17.77 Billion Rp-16.71 Billion Rp28.18 Billion Rp15.14 Billion

Diagnos Laboratorium Utama PT Tbk Earnings History — EPS Actual vs. Analyst Estimates

Track Diagnos Laboratorium Utama PT Tbk's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jun 30, 2023 -3.42 — —
Mar 31, 2023 -2.77 — —
Dec 31, 2022 0.40 — —
Sep 30, 2022 1.39 — —
Jun 30, 2022 1.62 — —
Mar 31, 2022 6.72 — —
Dec 31, 2021 0.26 — —
Sep 30, 2021 14.31 — —